Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
82.76
+0.37 (0.45%)
Sep 1, 2026, 1:34 PM EDT - Market open
Arrowhead Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $120 | Buy | Reiterates | $120 | +45.00% | Sep 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +45.00% | Sep 1, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 1, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $100 | Buy | Maintains | $100 | +20.83% | Aug 31, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $104 | Buy | Maintains | $104 | +25.66% | Aug 31, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 31, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $123 | Buy | Reiterates | $123 | +48.62% | Aug 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $126 | Buy | Reiterates | $126 | +52.25% | Aug 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.